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Bone metastatic breast cancer is a serious clinical problem resulting in hypercal-
cemia, bone fragility and pain, an understanding of the underlying molecular mecha-
nism would be highly valuable. The invasion of bone tissue by neoplastic cells usually 
very rapidly affects the balance between bone apposition and bone resorption. In or-
der to elucidate a mechanism for cancer-induced osteoclastogenesis, cells from human 
breast cancer cell line, MCF-7 were directly co-cultured with murine monocytes RAW 
264,7 type CRL 2278. The breast cancer cells in this coculture system secrete factors that 
act in a paracrine fashion to active osteoclasts: MCF-7 induced differentiation of multi-
nucleated cells by membrane-bound and soluble receptor activator of NF-kB ligand 
(RANKL) as shown by ELISA, Western blot analysis, transmission electron microscopy 
(TEM) and immunocytochemistry. RANKL is counteracted by Osteoprotegerin (OPG), 
which is a soluble decoy receptor for RANKL and blocks ligand binding to RANK, thus 
preventing the signalling required for osteoclast differentiation and activation. In the 
present study we observed that breast cancer cells expressed RANKL as two isoforms 
identified as transmembrane (Tm-isoform) and extracellular (Ex-isoform).The neutrali-
zation of RANKL by OPG resulted a complete inhibition of osteoclastic differentiation 
demonstrating that RANKL has an important role in the control of metastatic breast 
cancer behaviour. Our present finding indicates that the cells that were generated by co-
culture, in which we use breast cancer cells, were really osteoclasts and that this is due to 
the RANKL production. The implications are particularly noteworthy for the potential 
applications of drug that selectly regulate the expression of RANK-ligand isoform in the 
treatment of malignancies with bone osteolytic lesions.
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